Related Experiment Video
Updated: May 15, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
DNA methylation of RUNX3 in papillary thyroid cancer
Hee Ja Ko1, Bo Yeon Kim, Chan Hee Jung
1Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea.
Background/Aims:
The relationship between Runt-related transcription factor 3 (RUNX3) gene inactivation and various solid tumors has been reported; however, little information is available about RUNX3 in thyroid cancers.
Methods:
We evaluated the DNA methylation of RUNX3 in 13 papillary thyroid cancer tissues and four thyroid cancer cell lines. Additionally, using reverse transcriptase-polymerase chain reaction, we analyzed RUNX3 gene expression in several thyroid cancer cell lines after treating with the demethylating agent 5-aza-2'-deoxycytidine (DAC).
Results:
RUNX3 was hypermethylated in many thyroid cancer cell lines and in 10 of the 12 papillary thyroid cancer tissues. Treatment with DAC increased the expression of RUNX3 in some thyroid cancer cell lines.
Conclusions:
We suggest that RUNX3 is associated with thyroid carcinogenesis, and RUNX3 methylation is a potentially useful diagnostic marker for papillary thyroid cancer.
Insights
Runt-related transcription factor 3 (RUNX3) gene hypermethylation is linked to thyroid cancer. RUNX3 gene silencing may occur in thyroid tumors, and its methylation could serve as a diagnostic marker for papillary thyroid cancer.
Area of Science:
- Molecular oncology
- Cancer epigenetics
- Thyroid cancer research
Background:
- Runt-related transcription factor 3 (RUNX3) gene inactivation is implicated in various solid tumors.
- Limited data exists on the role of RUNX3 in the development of thyroid cancers.
Purpose of the Study:
- To investigate the DNA methylation status of the RUNX3 gene in thyroid cancer.
- To explore the correlation between RUNX3 gene expression and its methylation in thyroid cancer cell lines.
Main Methods:
- Evaluated RUNX3 DNA methylation in 13 papillary thyroid cancer tissues and 4 thyroid cancer cell lines.
- Utilized reverse transcriptase-polymerase chain reaction (RT-PCR) to analyze RUNX3 gene expression.
- Treated thyroid cancer cell lines with 5-aza-2'-deoxycytidine (DAC), a demethylating agent, to assess its effect on RUNX3 expression.
Main Results:
- RUNX3 gene hypermethylation was observed in multiple thyroid cancer cell lines.
- RUNX3 was hypermethylated in 10 out of 12 papillary thyroid cancer tissue samples.
- Treatment with DAC led to increased RUNX3 gene expression in some thyroid cancer cell lines.
Conclusions:
- RUNX3 gene is potentially associated with the carcinogenesis of thyroid cancer.
- RUNX3 methylation represents a promising diagnostic biomarker for papillary thyroid cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Inheritance of Chromatin Structures

